Our mission and strategy
Our mission is to help people do more, feel better and live longer.
We are focused on the delivery of three strategic priorities which aim to increase growth, reduce risk and improve our long-term financial performance.
These priorities are to grow a diversified global business, deliver more products of value, and simplify the operating model.
To this end, GSK has been creating a more balanced business and product portfolio, capable of delivering sustainable sales growth, and focused on our three business areas of Pharmaceuticals, Vaccines and Consumer Healthcare.
We have also changed our Research & Development (R&D) organisation across the globe to better sustain a pipeline of products that offer valuable improvements in treatment for patients and healthcare providers.
Operating responsibly and ensuring our values are embedded in our culture and decision-making also helps us better meet the expectations of society.
At GSK New Zealand, we continually assess how our company can evolve to meet those expectations, and exceed them.
GSK was the first pharmaceutical company to sign the AllTrials campaign for research transparency, and there has been a 60% increase in the volume of medicines supplied to Least Developed Countries since 2010.
In New Zealand, we have removed any financial incentives for our sales representatives linked to the sale of our medicines, in order to maintain our commitment to responsible and transparent decision-making at all times.
Read more about our strategic aims and priorities here.
Find out more about us
What we do
We are a science-led global healthcare company. We research and develop a broad range of innovative products in three primary areas of Pharmaceuticals, Vaccines and Consumer Healthcare.
The ‘Glaxo’ in GlaxoSmithKline has its origins in Wellington, where local entrepreneur Joseph Nathan established a trading company in 1873. Since then many companies have merged over the years to form GSK today.